Alkermes (ALKS) Operating Leases (2019 - 2026)
Alkermes (ALKS) reported Operating Leases of $61.98 million for Q2 2026, down 6.4% from $66.22 million a year earlier and down 2.8% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Alkermes posted Operating Leases of $63.25 million, down 8.8% from FY2024.
- Operating Leases has declined for five consecutive years, with a five-year compound annual growth rate of -11.9% (FY2020 to FY2025).
- By year, Operating Leases came in at $69.37 million in FY2024 (-8.4%), $75.71 million in FY2023 (-0.8%), $76.29 million in FY2022 (-26.8%) and $104.16 million in FY2021 (-12.8%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases since Q4 2019.
- Year over year, Operating Leases has now declined in each of the last 19 quarters, with an average decline of 8.1% over the last eight quarters.
- The high point for year-over-year Operating Leases in five years was Q3 2021 (growth of 11.5%); the low point was Q4 2022 (a decline of 26.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $63.75 million (Q1 2026), $63.25 million (Q4 2025) and $64.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.98 Mn |
| Mar 31, 2026 | 63.75 Mn |
| Dec 31, 2025 | 63.25 Mn |
| Sep 30, 2025 | 64.97 Mn |
| Jun 30, 2025 | 66.22 Mn |
| Mar 31, 2025 | 67.81 Mn |
| Dec 31, 2024 | 69.37 Mn |
| Sep 30, 2024 | 71.03 Mn |
| Jun 30, 2024 | 72.54 Mn |
| Mar 31, 2024 | 74.10 Mn |
| Dec 31, 2023 | 75.71 Mn |
| Sep 30, 2023 | 78.55 Mn |
| Jun 30, 2023 | 82.34 Mn |
| Mar 31, 2023 | 86.11 Mn |
| Dec 31, 2022 | 76.29 Mn |
| Sep 30, 2022 | 95.73 Mn |
| Jun 30, 2022 | 99.83 Mn |
| Mar 31, 2022 | 104.01 Mn |
| Dec 31, 2021 | 104.16 Mn |
| Sep 30, 2021 | 107.86 Mn |
API Access
Alkermes Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();